The B-vitamin family has a quiet but persistent role in schizophrenia research. They sit at the centre of the methylation cycle, are involved in monoamine neurotransmitter synthesis, and become depleted in patterns that show up disproportionately in people with serious mental illness. None of that means a B-vitamin pill cures schizophrenia. It does mean that screening and, in selected cases, supplementation has a genuine evidence base worth understanding.
People with schizophrenia have higher rates of low folate and B12 than the general population, and targeted supplementation may modestly help symptoms — particularly negative symptoms — in deficient patients.
What B6, B9 (folate), and B12 actually do
These three vitamins jointly support methylation, the chemistry by which the body adds and removes methyl groups on DNA, neurotransmitters, and many other molecules. They also help recycle homocysteine, an amino acid that becomes toxic when it accumulates. Folate (B9) and B12 in particular are needed to convert homocysteine back into methionine; B6 supports a parallel pathway. When any of the three runs low, homocysteine rises.
The homocysteine link to schizophrenia
Multiple meta-analyses, including one in JAMA Psychiatry by Muntjewerff and colleagues (available via PubMed), have found that people with schizophrenia have meaningfully higher average homocysteine levels and lower folate levels than matched controls. Whether elevated homocysteine causes schizophrenia symptoms or simply marks something else (smoking, poor diet, antipsychotic effects) is unsettled. But the association is consistent.
The MTHFR variant
A common gene variant, MTHFR C677T, reduces the activity of an enzyme that converts folate into its active form, methylfolate. People who carry two copies (about 10–15% of the population, depending on ancestry) have somewhat higher homocysteine and may benefit more from supplementation with the active form (L-methylfolate) than with regular folic acid. Genetic testing for MTHFR is widely available; whether it should change your treatment is more controversial — most psychiatric organisations consider it informative but not mandatory.
What supplementation trials have shown
The most influential trial is a 2013 randomised study by Roffman and colleagues at Massachusetts General Hospital (published in JAMA Psychiatry; PubMed). It tested high-dose folic acid plus B12 added to standard treatment in patients with schizophrenia and found modest improvements in negative symptoms, with the largest benefit in patients with the high-risk MTHFR variant. A 2017 follow-up using L-methylfolate (the active form) showed further benefit on negative symptoms.
Several other small trials have replicated the general signal: folate plus B12, and sometimes B6, can produce modest but real reductions in negative symptoms in people with schizophrenia who are deficient or who carry inefficient methylation genes. Effects on positive symptoms have been smaller and less consistent.
Where the evidence is weak
- B vitamins do not appear to substitute for antipsychotics
- Effects on positive symptoms are small at best
- People with normal folate and B12 levels and no MTHFR variant gain little
- "More is better" is not true — high-dose folic acid in non-deficient individuals has its own concerns
Why deficiency is so common in schizophrenia
Several factors stack up:
- Diets often heavy in processed foods and low in leafy greens, legumes, eggs, and meat
- Heavy smoking, which depletes B12
- Some antipsychotics may modestly affect B-vitamin metabolism
- Comorbid alcohol use disorder, which directly impairs absorption
- Reduced engagement with primary care, which means deficiencies aren't caught
What sensible practice looks like
A grounded approach, supported by the National Institutes of Health Office of Dietary Supplements:
- Ask your primary care or psychiatric prescriber to check serum folate, B12, and homocysteine. These are inexpensive, routine tests.
- If anything is low, replace it under medical supervision. B12 deficiency in particular often requires injections or high oral doses.
- If symptoms are dominated by negative symptoms and methylation looks impaired, discuss whether a trial of L-methylfolate plus B12 makes sense as an add-on.
- Eat the source food where you can — leafy greens, beans, eggs, fish, fortified cereals.
Cautions
High-dose folate can mask vitamin B12 deficiency, allowing irreversible nerve damage to develop silently. Always check B12 before starting high-dose folate. Very high doses of B6 (over 100 mg/day for prolonged periods) can cause peripheral nerve damage. Treat B vitamins like medications, not snacks.
The honest bottom line
B vitamins are not a treatment for schizophrenia in the way an antipsychotic is. But screening for deficiency is cheap and reasonable, and selective supplementation in deficient patients — especially those with prominent negative symptoms or known MTHFR variants — is supported by genuine, if modest, evidence. As with most things in psychiatry, the win is in personalisation, not in adding another supplement to everyone's routine.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.